Cystatin C for the assessment of GFR in neonates with congenital renal anomalies

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3382-3384

  Filler, Guido ^a,b   Grimmer, Joanne ^a   Huang, Shih Han Susan ^a   Bariciak, Erika ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

trace protein; congenital renal abnormalities; cystatin C

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

DISEASE MARKER; DOWN REGULATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY MALFORMATION; NEPHRON; NEWBORN; NEWBORN ASSESSMENT; NOTE; PLACENTAL TRANSFER; PREECLAMPSIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REFERENCE VALUE; THIRD TRIMESTER PREGNANCY; UPREGULATION;

BIOLOGICAL MARKERS; CYSTATIN C; FEMALE; HUMANS; KIDNEY DISEASES; MALE;

EID: 84865793007     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs253     Document Type: Note

References (26)

1. Gubhaju L, Sutherland MR, Black MJ. Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 2011; 18: 322-333.
2. Choi YJ, Baranowska-Daca E, Nguyen V et al. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int 2000; 58: 1481-1491.
3. Truong LD, Sheikh-Hamad D, Chakraborty S et al. Cell apoptosis and proliferation in obstructive uropathy. Sem Nephrol 1998; 18: 641-651.
4. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132.
5. Matsuoka H, Nakashima Y, Oshima K. Prognostic significance of the number of renal glomeruli in reflux nephropathy. BJU Int 2006; 98: 172-176.
6. Keller G, Zimmer G, Mall G et al. Nephron number in patients with primary hypertension. N Eng J Med 2003; 348: 101-108.
7. Sanghvi KP, Merchant RH, Gondhalekar A et al. Antenatal diagnosis of congenital renal malformations using ultrasound. J Trop Pediatr 1998; 44: 235-240.
8. Livera LN, Brookfield DS, Egginton JA et al. Antenatal ultrasonography to detect fetal renal abnormalities: a prospective screening programme. Br Med J 1989; 298: 1421-1423.
9. Halek J, Flogelova H, Michalkova K et al. Diagnostic accuracy of postnatal ultrasound screening for urinary tract abnormalities. Pediatr Nephrol 2010; 25: 281-287.
10. Filler G, Browne R, Seikaly MG. Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children. Pediatr Transplant 2003; 7: 18-24.
11. Filler GM. The challenges of assessing acute kidney injury in infants. Kidney Int 2011; 80: 567-568.
12. Bariciak E, Yasin A, Harrold J et al. Preliminary reference intervals for cystatin C and beta-trace protein in preterm and term neonates. Clin Biochem 2011; 44: 1156-1159.
13. Pham-Huy A, Leonard M, Lepage N et al. Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol 2003; 169: 2312-2315.
14. Filler G, Bokenkamp A, Hofmann Wet al. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38: 1-8.
15. Sharma AP, Kathiravelu A, Nadarajah R et al. Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 2009; 24: 470-474.
16. Bokenkamp A, Dieterich C, Dressler F et al. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 2001; 185: 468-475.
17. Parvex P, Combescure C, Rodriguez M et al. Is cystatin C a promising marker of renal function, at birth, in neonates prenatally diagnosed with congenital kidney anomalies? Nephrol Dial Transplant 2012.
18. Schreuder MF, Westland R, van Wijk JA. Unilateral multicystic dysplastic kidney: a meta-analysis of observational studies on the incidence, associated urinary tract malformations and the contralateral kidney. Nephrol Dial Transplant 2009; 24: 1810-1818.
19. Pedersen M, Karstoft K, Lodrup A et al. Advantages and controversies in the era of intrarenal volumetry. Am J Nephrol 2011; 33 (Suppl 1): 40-45.
20. Plebani M, Mussap M, Bertelli L et al. [Determination of blood cystatin C in pregnant women during labor and in their newborns]. Pediatr Med Chir 1997; 19: 325-329.
21. Cataldi L, Mussap M, Bertelli L et al. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999; 16: 287-295.
22. Finney H, Newman DJ, Thakkar H et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000; 82: 71-75.
23. Lindsay RM, Huang SH, Filler G. Cystatin C measurements in the assessment of residual renal function, dialysis adequacy, and beyond. Perit Dial Int 2010; 30: 437-439.
24. Akbari A, Lepage N, Keely E et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy. BJOG 2005; 112: 575-578.
25. Anderson UD, Olsson MG, Kristensen KH et al. Review: Biochemical markers to predict preeclampsia. Placenta 2012; 33 (Suppl): S42-S47.
26. Benlamri A, Nadarajah R, Yasin A et al. Development of a betatrace protein based formula for estimation of glomerular filtration rate. Pediatr Nephrol 2010; 25: 485-490.